Screening for Albuminuria下载

A quick pocket tool to help medical professionals assess and treat albuminuria in people with diabetes and other high risk patients. Designed for rapid, convenient, point-of-care intervention whenever and wherever you need it. Content is adapted from KDOQI evidence-based clinical practice guidelines and recommendations from the National Kidney Foundation.
Features:
Designed for rapid, convenient, point-of-care intervention. With a few quick taps, you will:
•Evaluate diabetic patients for albuminuria and chronic kidney disease (CKD)
•Use evidence-based strategies to assess and treat
•Access an interactive, clinical action plan that can be individualized for your patients
Simple, quick, and organized by:
•What is Albuminuria?
•Why screen for albuminuria in high risk patients?
•When to screen
•How to screen
•Follow-up using a simple, interactive decision-making algorithm
•Facts about albuminuria, diabetes, and chronic kidney disease
Facts About Chronic Kidney Disease
•Kidney disease is common, harmful, and treatable.
•26 million American have kidney disease – but most do not know they have it. Millions more are at increased risk.
•High risk groups include those with diabetes, hypertension, and a family history of kidney disease. African Americans, Hispanics, Asian or Pacific Islanders, Native Americans and seniors are also at increased risk.
•Early detection can slow the progression of kidney disease.
•Once kidneys fail, patients need dialysis or a transplant to survive.
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention, and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families, and tens of millions of Americans at risk.
By supporting the National Kidney Foundation, you directly influence and positively impact the lives of those at risk for kidney disease, those living with chronic kidney disease, and those who care for and about them.
Learn more at www.kidney.org
30 East 33rd Street
New York, NY 10016
www.kidney.org
800-622-9010
一个快速的口袋工具，以帮助医疗专业人员评估和治疗蛋白尿的糖尿病人等高危患者。专为护理点的快速，便捷，干预，无论何时何地您需要它。内容是改编自美国国家肾脏基金会KDOQI循证临床实践指南和建议。
产品特点：
专为护理点的快速，方便，干预。用几个简单的水龙头，你会：
•评估糖尿病患者的蛋白尿和慢性肾脏病（CKD）
•使用证据为基础的战略，评估和治疗
•访问可以个性化你的病人的互动，临床行动计划
简单，快捷，并通过组织：
•什么是蛋白尿？
•为什么屏幕在高风险患者蛋白尿？
•当屏幕
•如何筛选
•使用简单，互动决策算法跟进
•关于蛋白尿，糖尿病和慢性肾脏病的事实
事实关于慢性肾脏病
•肾脏​​疾病是常见​​的，有害的，可以治疗的。
•2600万美国人患有肾脏疾病 - 但大多数人不知道他们有它。数以百万计更是在增加的风险。
•高风险群体包括那些患有糖尿病，高血压，肾脏疾病的家族史。非裔美国人，西班牙裔，亚裔或太平洋岛民，美国本地人和老年人也面临更大的风险。
•早期发现可以减缓肾脏疾病的进展。
•一旦肾脏出现问题，患者需要透析或移植才能存活。
全国肾脏基金会是在美国主导的组织，致力于意识，预防和治疗肾脏病的几十万的医疗保健专业人士，数百万人面临危险的数以千万计的美国人的病人和他们的家人，和。
通过支持全国肾脏基金会，直接影响和积极影响那些生活在危险的肾脏疾病，那些患有慢性肾脏病，和那些谁关心和了解他们。
要了解详情，www.kidney.org
30东33街
纽约，纽约州10016
www.kidney.org
800-622-9010

优化系统性能，体验更顺畅。